埃及可以在本地生產中國科興疫苗

 [Photo/Xinhua]

Egyptian Health Minister Hala Zayed said on Sunday that Egypt will start locally producing China's Sinovac COVID-19 vaccine in June.
埃及衛(wèi)生部長扎耶德5月9日在開羅的一個新聞發(fā)布會上表示，埃及將于6月開始在本地生產中國科興公司研發(fā)的新冠疫苗。

During a news conference in Cairo, the minister said that the first 2 million doses will be produced in June at the plants of the Egyptian Holding Company for Biological Products and Vaccines (VACSERA).
投產首月，埃及生物和疫苗制品控股公司(VACSERA)的工廠將生產首批200萬劑科興新冠疫苗。

"We will receive the first shipment of the raw materials needed to manufacture the vaccine on May 18," Zayed told reporters, adding that 40 million doses will be produced in the first year.
扎耶德告訴記者："我們將在5月18日接收到首批新冠肺炎疫苗原材料，今年將生產4000萬劑新冠疫苗。"

Zayed noted that two agreements were signed between Sinovac and the VACSERA in April, with the first one enabling the Egyptian side to obtain the expertise and technical assistance to produce the vaccine, while the second giving VACSERA the license to manufacture and pack the vaccine in its factories.
扎耶德說，今年4月VACSERA與科興公司簽訂了兩份協(xié)議，根據第一份協(xié)議，科興公司將為VACSERA提供與疫苗相關的所有技術信息，并提供技術援助，這將令埃及可以在本地生產科興的疫苗。根據第二份協(xié)議規(guī)定科興公司向VACSERA授予許可證，允許VACSERA在自己的生產設施中進行疫苗產品的灌裝、包裝等。